Baird Financial Group, Inc. Acadia Pharmaceuticals Inc Transaction History
Baird Financial Group, Inc.
- $54.4 Billion
- Q2 2025
Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
354Shares Held
164MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$929 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$329 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$261 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$195 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$134 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.5B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...